Tellimer logo
Search icon
Equity Analysis
/United States of America

US : InflaRx N.V. - IFRX | 1Q21 Update: FDA Not Suppurativa of IHS4 Endpoint in HS Yet

    Ryan Deschner
    Timur Ivannikov
    12 May 2021
    Published by


    Tellimer | Start Following

    Start following your markets today

    Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.